Abstract
Purpose
Intrathecal administration of serotonin (5-HT) is antinociceptive through the involvement of spinal cord γ-aminobutyric acid (GABA) receptors. Therefore, 5-HT would interact with the GABA agonist, midazolam, which is well known to exert spinally mediated antinociception in the spinal cord. The present study investigated the antinociceptive interaction between spinally administered 5-HT and midazolam, using two different rat nociceptive models.
Methods
Sprague-Dawley rats with lumbar intrathecal catheters were tested for their thermal tail withdrawal response and paw flinches induced by formalin injection after the intrathecal administration of midazolam or 5-HT, or the midazolam/ HT combination. The effects of the combination were tested by isobolographic analysis, using the combination of each 1, 1/2, 1/4, 1/8, and 1/16 of the 50% effective dose (ED50). The total fractional dose was calculated. Behavioral side effects were also examined.
Results
5-HT alone and midazolam alone both showed dose-dependent antinociception in both the tail flick test and the formalin test. The ED50 of the combination was not different from the calculated additive value either in the tail flick test or in phase 2 of the formalin test, but it was significantly smaller than the calculated additive value in phase 1 of the formalin test. The total fractional dose value was 0.90 in the tail flick test, 0.093 in phase 1 of the formalin test, and 1.38 in phase 2 of the formalin test. The agitation, allodynia, or motor disturbance observed with either agent alone was not seen with the combination treatment.
Conclusion
The antinociceptive effects of intrathecal midazolam and 5-HT were additive on thermal acute and inflammatory facilitated stimuli, and synergistic on inflammatory acute stimulation.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Edwards M, Serrao JM, Gent JP, Goodchild CS. On the mechanism by which midazolam causes spinally mediated analgesia. Anesthesiology. 1990;73:273–277.
Nishiyama T. Analgesic effects of systemic midazolam: comparison with intrathecal administration. Can J Anesth. 2006;53:1004–1009.
Bloom FE, Hoffer BJ, Nelson C. The physiology and pharmacology of serotonin mediated synapses. In: Barchas J, Usdin E, editors. Serotonin and behavior. New York: Academic; 1973. p. 249–261.
Hylden JLK, Wilcox GL. Intrathecal serotonin in mice: analgesia and inhibition of a spinal action of substance P. Life Sci. 1983;33:789–795.
Ali Z, Wu G, Kozlov A, Barasi S. The actions of 5-HT1 agonists and antagonists on nociceptive processing in the rat spinal cord: results from behavioral and electrophysiological studies. Brain Res. 1994;661:83–90.
Bardin L, Bardin M, Lavarenne J, Eschalier A. Effect of intrathecal serotonin on nociception in rats: influence of the pain test used. Exp Brain Res. 1997;113:81–87.
Calejesan AA, Chang MHC, Zhuo M. Spinal serotonergic receptors mediate facilitation of a nociceptive reflex by subcutaneous formalin injection into the hindpaw in rats. Brain Res. 1998;798:46–54.
Vaught JL, Scott R. Interactions of substance P antagonists with serotonin in the mouse spinal cord. Peptides. 1988;9:909–913.
Nadeson R, Guo Z, Porter V, Gent JP, Goodchild CS. GABAA receptors and spinally-mediated antinociception in rats. J Pharmacol Exp Ther. 1996;278:620–626.
Goodchild CS, Guo Z, Freeman J, Gent JP. 5-HT spinal antinociception involves mu opioid receptors: cross tolerance and antagonist studies. Br J Anaesth. 1997;78:563–569.
Tallarida RJ, Porreca F, Cowan A. Statistical analysis of drug — drug and site — site interactions with isobologram. Life Sci. 1989;45:947–961.
Advokat C, Rutherford D. Selective antinociceptive effect of excitatory amino acid antagonists in intact and acute spinal rats. Pharmacol Biochem Behav. 1995;51:855–860.
Puig S, Sorkin LS. Formalin-evoked activity in identified primary afferent fibres: systemic lidocaine suppresses phase 2 activity. Pain. 1995;64:345–357.
Aanonsen LM, Wilcox GL. Muscimol, γ-aminobutyric acid receptors and excitatory amino acids in the mouse spinal cord. J Pharmacol Exp Ther. 1989;248:1034–1038.
Alhaider AA, Lei SZ, Wilcox GL. Spinal 5-HT3 receptormediated antinociception: possible release of GABA. J Neurosci. 1991;11:1881–1888.
Zhang YQ, Yang ZL, Gao X, Wu GC. The role of 5-HT1A and 5-HT1B receptors in modulating spinal nociceptive transmission in normal and carageenan inflammatory rats. Pain. 2001;92:201–211.
Nadeson R, Goodchild CS. Antinociceptive role of 5-HT1A receptors in rat spinal cord. Br J Anaesth. 2002;88:679–684.
Tao R, Ma Z, Auerbach SB. Differential regulation of 5-hydroxytryptamine release by GABAA and GABAB receptors in midbrain raphe nuclei and forebrain of rats. Br J Pharmacol. 1996;119:1375–1384.
Giordano J. Analgesic profile of centrally administered 2-methylserotonin against acute pain in rats. Eur J Pharmacol. 1991;199:233–236.
Nazar M, Siemiatkowski M, Czlonkowska A, Sienkiewicz-Jarosz H, Plaznik A. The role of the hippocampus and 5-HT/GABA interaction in the central effects of benzodiazepine receptor ligands. J Neural Transm. 1999;106:369–381.
Semba K, Adachi N, Arai T. Facilitation of serotonergic activity and amnesia in rats caused by intravenous anesthetics. Anesthesiology. 2005;102:616–623.
Author information
Authors and Affiliations
About this article
Cite this article
Nishiyama, T. Interaction between midazolam and serotonin in spinally mediated antinociception in rats. J Anesth 23, 249–255 (2009). https://doi.org/10.1007/s00540-009-0740-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00540-009-0740-9